3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
37
Melanoma
17
Prostatic Neoplasms
16
Lung Neoplasms
14
Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
9
Precancerous Conditions
8
Lymphoma
8
Uterine Cervical Neoplasms
6
Pancreatic Neoplasms
6
Leukemia
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms, Male
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, Follicular
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Barrett Esophagus
5
Adenocarcinoma Of Esophagus
5
Salivary Gland Neoplasms
4
Recurrence
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Interventions
Dexamethasone
2
ixazomib
1
birtamimab
1
Standard of Care
1
Rosiglitazone
1
Neurofeedback
1
Methotrexate
1
Melphalan
1
Mass Screening
1
Magnetic Resonance Imaging
1
Lysine Acetyltransferase 5
1
Hormones
1
Exercise
1
Cyclophosphamide
1
Control Groups
1
Cholinesterase Inhibitors
1
Calcium Dobesilate
1
Bortezomib
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Alzheimer Disease
×
Biopsy
×
Clear all
NCT03923920
2021-12-22
ALF
The Cleveland Clinic
Completed
200 enrolled